{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T23:25:03Z","timestamp":1783639503463,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T00:00:00Z","timestamp":1694822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T00:00:00Z","timestamp":1694822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"crossref","award":["NIHR130581"],"award-info":[{"award-number":["NIHR130581"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"crossref","award":["NIHR130581"],"award-info":[{"award-number":["NIHR130581"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"crossref","award":["NIHR130581"],"award-info":[{"award-number":["NIHR130581"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"crossref","award":["NIHR130581"],"award-info":[{"award-number":["NIHR130581"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"crossref","award":["NIHR130581"],"award-info":[{"award-number":["NIHR130581"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"crossref","award":["NIHR130581"],"award-info":[{"award-number":["NIHR130581"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>There is concern that the COVID-19 pandemic altered the management of common infections in primary care. This study aimed to evaluate infection-coded consultation rates and antibiotic use during the pandemic and how any change may have affected clinical outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>With the approval of NHS England, a retrospective cohort study using the OpenSAFELY platform analysed routinely collected electronic health data from GP practices in England between January 2019 and December 2021. Infection coded consultations and antibiotic prescriptions were used estimate multiple measures over calendar months, including age-sex adjusted prescribing rates, prescribing by infection and antibiotic type, infection consultation rates, coding quality and rate of same-day antibiotic prescribing for COVID-19 infections. Interrupted time series (ITS) estimated the effect of COVID-19 pandemic on infection-coded consultation rates. The impact of the pandemic on non- COVID-19 infection-related hospitalisations was also estimated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Records from 24 million patients were included. The rate of infection-related consultations fell for all infections (mean reduction of 39% in 2020 compared to 2019 mean rate), except for UTI which remained stable. Modelling infection-related consultation rates highlighted this with an incidence rate ratio of 0.44 (95% CI 0.36\u20130.53) for incident consultations and 0.43 (95% CI 0.33\u20130.54) for prevalent consultations. Lower respiratory tract infections (LRTI) saw the largest reduction of 0.11 (95% CI 0.07\u20130.17). Antibiotic prescribing rates fell with a mean reduction of 118.4 items per 1000 patients in 2020, returning to pre-pandemic rates by summer 2021. Prescribing for LRTI decreased 20% and URTI increased 15.9%. Over 60% of antibiotics were issued without an associated same-day infection code, which increased during the pandemic. Infection-related hospitalisations reduced (by 62%), with the largest reduction observed for pneumonia infections (72.9%). Same-day antibiotic prescribing for COVID-19 infection increased from 1 to 10.5% between the second and third national lockdowns and rose again during 2022.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Changes to consultations and hospital admissions may be driven by reduced transmission of non-COVID-19 infections due to reduced social mixing and lockdowns. Inconsistencies in coding practice emphasises the need for improvement to inform new antibiotic stewardship policies and prevent resistance to novel infections.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13756-023-01280-6","type":"journal-article","created":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T11:01:41Z","timestamp":1694862101000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["The impact of the COVID-19 pandemic on the treatment of common infections in primary care and the change to antibiotic prescribing in England"],"prefix":"10.1186","volume":"12","author":[{"given":"Ya-Ting","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Fahmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren M.","family":"Ashcroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Massey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"MacKenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Mehrkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian C. J.","family":"Bacon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Goldacre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieran","family":"Hand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tjeerd","family":"van Staa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Palin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,16]]},"reference":[{"key":"1280_CR1","unstructured":"English Surveillance Programme for Antimicrobial Utilisation and Resistance: report 2019 to 20202021 08 01."},{"issue":"36","key":"1280_CR2","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.15585\/mmwr.mm6936a4","volume":"69","author":"ME Czeisler","year":"2020","unstructured":"Czeisler ME, Marynak K, Clarke KEN, Salah Z, Shakya I, Thierry JM, et al. Delay or Avoidance of Medical Care Because of COVID-19-Related Concerns - United States, June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(36):1250\u20137.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"1280_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30917-8","volume":"21","author":"R Armitage","year":"2021","unstructured":"Armitage R, Nellums LB. Antibiotic prescribing in general practice during COVID-19. Lancet Infect Dis. 2021;21(6): e144.","journal-title":"Lancet Infect Dis"},{"key":"1280_CR4","unstructured":"RCGP survey provides snapshot of how GP care is accessed in latest stages of pandemic 2021."},{"key":"1280_CR5","doi-asserted-by":"crossref","unstructured":"Hussain AZ PV, Hadi MA. Impact of the COVID-19 Pandemic on the Prescribing Patterns of First-Line Antibiotics in English Primary Care: A Longitudinal Analysis of National Prescribing Dataset. Antibiotics (Basel). 2021.","DOI":"10.3390\/antibiotics10050591"},{"key":"1280_CR6","doi-asserted-by":"crossref","unstructured":"Andrews A, Bou-Antoun S, Guy R, Brown C, Hopkin S, Gerver S. respiratory antibacterial prescribing in primary care and the COVID-19 pandemic in England, winter season 2020\u201321. J Antimicrobal Chemotherapy. 2022:799\u2013802.","DOI":"10.1093\/jac\/dkab443"},{"issue":"1","key":"1280_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jinf.2023.05.010","volume":"87","author":"X Zhong","year":"2023","unstructured":"Zhong X, Pate A, Yang YT, Fahmi A, Ashcroft DM, Goldacre B, et al. The impact of COVID-19 on antibiotic prescribing in primary care in England: evaluation and risk prediction of appropriateness of type and repeat prescribing. J Infect. 2023;87(1):1\u201311.","journal-title":"J Infect"},{"key":"1280_CR8","doi-asserted-by":"crossref","unstructured":"Monnet DL, Harbarth S. Will coronavirus disease (COVID-19) have an impact on antimicrobial resistance? Euro Survelliance. 2020.","DOI":"10.2807\/1560-7917.ES.2020.25.45.2001886"},{"key":"1280_CR9","doi-asserted-by":"crossref","unstructured":"Rawson T, Moore L, Nina Z, Skolimowska K, Gilchrist M, Giovanni S, et al. Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing. Infectious Diseases Society of America; 2020.","DOI":"10.1093\/cid\/ciaa530"},{"key":"1280_CR10","doi-asserted-by":"crossref","unstructured":"Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020:266\u201375.","DOI":"10.1016\/j.jinf.2020.05.046"},{"key":"1280_CR11","doi-asserted-by":"crossref","unstructured":"Langford BJ, So M, Raybardhan S, Leung V, Soucy J-PR, Westwood D, et al. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Clin Microbiol Infect. 2021:520\u201331.","DOI":"10.1016\/j.cmi.2020.12.018"},{"key":"1280_CR12","doi-asserted-by":"crossref","unstructured":"Nori P, Cowman K, Chen V. and fungal coinfections in COVID-19 patients hospitalized during the New York City pandemic surge. Infect Control Hosp Epidemiol. 2020.","DOI":"10.1017\/ice.2020.368"},{"key":"1280_CR13","doi-asserted-by":"crossref","unstructured":"Zhu N, Aylin P, Rawson T, Gilchrist M, Majeed A, Holmes A. Investigating the impact of COVID-19 on primary care antibiotic prescribing in North West London across two epidemic waves. Clin Microbiol Infect. 2021.","DOI":"10.1016\/j.cmi.2021.02.007"},{"key":"1280_CR14","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-Ba\u00f1o J RG, Schultsz C, Tacconelli E, Murthy S, Ohmagari N, Holmes A, Bachmann T, Goossens H, Canton R, Roberts AP, Henriques-Normark B, Clancy CJ, Huttner B, Fagerstedt P, Lahiri S, Kaushic C, Hoffman SJ, Warren M, Zoubiane G, Essack. Key considerations on the potential impacts of the COVID-19 pandemic on antimicrobial resistance research and surveillance. Am J Respirat Crit Care Med. 2021.","DOI":"10.1093\/trstmh\/trab048"},{"key":"1280_CR15","doi-asserted-by":"crossref","unstructured":"Borek AJ MK, McLeod M, Campbell A, Hayhoe B, Butler CC, Morrell L, Roope LSJ, Holmes A, Walker AS, Tonkin-Crine S. Impact of the COVID-19 pandemic on community antibiotic prescribing and stewardship: a qualitative interview study with general practitioners in England. Antibiotics (Basel). 2021.","DOI":"10.1101\/2021.11.19.21266529"},{"issue":"5","key":"1280_CR16","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383.","journal-title":"J Chronic Dis"},{"key":"1280_CR17","unstructured":"MacKenna B. What is the dm+d? The NHS Dictionary of Medicines and Devices. 2019."},{"issue":"7011","key":"1280_CR18","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1136\/bmj.311.7011.991","volume":"311","author":"DC Lloyd","year":"1995","unstructured":"Lloyd DC, Harris CM, Roberts DJ. Specific therapeutic group age-sex related prescribing units (STAR-PUs): weightings for analysing general practices\u2019 prescribing in England. BMJ. 1995;311(7011):991\u20134.","journal-title":"BMJ"},{"key":"1280_CR19","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.eclinm.2018.12.003","volume":"6","author":"EC Hope","year":"2018","unstructured":"Hope EC, Crump RE, Hollingsworth TD, Smieszek T, Robotham JV, Pouwels KB. Identifying English practices that are high antibiotic prescribers accounting for comorbidities and other legitimate medical reasons for variation. EClinicalMedicine. 2018;6:36\u201341.","journal-title":"EClinicalMedicine"},{"issue":"706","key":"1280_CR20","doi-asserted-by":"publisher","first-page":"e331","DOI":"10.3399\/BJGP.2020.1051","volume":"71","author":"E Rezel-Potts","year":"2021","unstructured":"Rezel-Potts E, L\u2019Esperance V, Gulliford MC. Antimicrobial stewardship in the UK during the COVID-19 pandemic: a population-based cohort study and interrupted time-series analysis. Br J Gen Pract. 2021;71(706):e331\u20138.","journal-title":"Br J Gen Pract"},{"issue":"8","key":"1280_CR21","doi-asserted-by":"publisher","first-page":"e21257","DOI":"10.2196\/21257","volume":"22","author":"NC Chiu","year":"2020","unstructured":"Chiu NC, Chi H, Tai YL, Peng CC, Tseng CY, Chen CC, et al. Impact of wearing masks, hand hygiene, and social distancing on influenza, enterovirus, and all-cause pneumonia during the coronavirus pandemic: Retrospective National Epidemiological Surveillance Study. J Med Internet Res. 2020;22(8):e21257.","journal-title":"J Med Internet Res"},{"issue":"1","key":"1280_CR22","doi-asserted-by":"publisher","first-page":"dlad012","DOI":"10.1093\/jacamr\/dlad012","volume":"5","author":"Z Yang","year":"2023","unstructured":"Yang Z, Bou-Antoun S, Gerver S, Cowling TE, Freeman R. Sustained increases in antibiotic prescriptions per primary care consultation for upper respiratory tract infections in England during the COVID-19 pandemic. JAC Antimicrob Resist. 2023;5(1):dlad012.","journal-title":"JAC Antimicrob Resist."},{"key":"1280_CR23","doi-asserted-by":"crossref","unstructured":"McCloskey AP, Malabar L, McCabe PG, Gitsham A, Jarman I. Antibiotic prescribing trends in primary care 2014\u20132022. Res Social Adm Pharm. 2023.","DOI":"10.1016\/j.sapharm.2023.05.001"},{"issue":"9","key":"1280_CR24","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/S2213-2600(21)00310-6","volume":"9","author":"CC Butler","year":"2021","unstructured":"Butler CC, Yu LM, Dorward J, Gbinigie O, Hayward G, Saville BR, et al. Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. Lancet Respir Med. 2021;9(9):1010\u201320.","journal-title":"Lancet Respir Med"},{"key":"1280_CR25","doi-asserted-by":"crossref","unstructured":"Bryce C, O'Connell MD, Dale J, Underwood M, Atherton H. Online and telephone access to general practice: a cross-sectional patient survey. BJGP Open. 2021;5(4).","DOI":"10.3399\/BJGPO.2020.0179"},{"issue":"2","key":"1280_CR26","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/fampra\/cmac101","volume":"40","author":"J Parsons","year":"2023","unstructured":"Parsons J, Rahman S, Bryce C, Atherton H. Use of a pharmacy-based GP video consultation service: a mixed methods study. Fam Pract. 2023;40(2):241\u20137.","journal-title":"Fam Pract"},{"issue":"5","key":"1280_CR27","doi-asserted-by":"publisher","first-page":"e068176","DOI":"10.1136\/bmjopen-2022-068176","volume":"13","author":"J Williams","year":"2023","unstructured":"Williams J, Johns G, Phipps K, Khalil S, Ogonovsky M, Ahuja A. Online survey and interview evaluation to explore the use of video consulting among Allied Health Professionals during the COVID-19 pandemic. BMJ Open. 2023;13(5):e068176.","journal-title":"BMJ Open"},{"key":"1280_CR28","doi-asserted-by":"crossref","unstructured":"Gulliford MC, Charlton J, Boiko O. Chapter 6, Patterns of antibiotic prescribing in UK primary care from 2002 to 2017. Safety of reducing antibiotic prescribing in primary care: a mixed-methods study. 9. Health Services and Delivery Research: Southampton (UK): NIHR J. Library. 2021.","DOI":"10.3310\/hsdr09090"},{"key":"1280_CR29","doi-asserted-by":"crossref","unstructured":"Van Staa T, Li Y, Gold N, Chadborn T, Welfare W, Palin V, et al. Comparing antibiotic prescribing between clinicians in UK primary care: an analysis in a cohort study of eight different measures of antibiotic prescribing. BMJ Qual Saf. 2022.","DOI":"10.1136\/bmjqs-2020-012108"},{"key":"1280_CR30","doi-asserted-by":"crossref","unstructured":"Krockow EM, Harvey EJ, Ashiru-Oredope D. Addressing long-term and repeat antibiotic prescriptions in primary care: considerations for a behavioural approach. BMJ Qual Saf. 2022.","DOI":"10.1136\/bmjqs-2022-014821"},{"key":"1280_CR31","doi-asserted-by":"publisher","first-page":"g5493","DOI":"10.1136\/bmj.g5493","volume":"349","author":"CJ Currie","year":"2014","unstructured":"Currie CJ, Berni E, Jenkins-Jones S, Poole CD, Ouwens M, Driessen S, et al. Antibiotic treatment failure in four common infections in UK primary care 1991\u20132012: longitudinal analysis. BMJ. 2014;349:g5493.","journal-title":"BMJ"},{"issue":"1","key":"1280_CR32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12916-020-1504-5","volume":"18","author":"TP van Staa","year":"2020","unstructured":"van Staa TP, Palin V, Li Y, Welfare W, Felton TW, Dark P, et al. The effectiveness of frequent antibiotic use in reducing the risk of infection-related hospital admissions: results from two large population-based cohorts. BMC Med. 2020;18(1):40.","journal-title":"BMC Med"},{"key":"1280_CR33","unstructured":"NHS Digital. Data Security and Protection Toolkit. 2020 [cited 2022."},{"key":"1280_CR34","unstructured":"NHS Digital. ISB1523: Anonymisation Standard for Publishing Health and Social Care Data. 2020."},{"key":"1280_CR35","unstructured":"Secretary of State for Health and Social Care - UK Government. Coronavirus (COVID-19): notification to organisations to share information. 2022."},{"key":"1280_CR36","unstructured":"Secretary of State for Health and Social Care - UK Government. Coronavirus (COVID-19): notice under Regulation 3(4) of the Health Service (Control of Patient Information) Regulations 2002. 2020."},{"key":"1280_CR37","unstructured":"Confidentiality Advisory Group Health Research Authority."}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-023-01280-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-023-01280-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-023-01280-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T02:21:58Z","timestamp":1700619718000},"score":1,"resource":{"primary":{"URL":"https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-023-01280-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,16]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1280"],"URL":"https:\/\/doi.org\/10.1186\/s13756-023-01280-6","relation":{},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,16]]},"assertion":[{"value":"5 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Health Research Authority and NHS Research Ethics Committee [REC reference 21\/SC\/0287]. The OpenSAFELY data science platform is funded by the Wellcome Trust. The views expressed are those of the authors and not necessarily those of NHS England, Public Health England or the Department of Health and Social Care. Funders had no role in the study design, collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"NHS England is the data controller for OpenSAFELY-TPP; TPP is the data processor; all study authors using OpenSAFELY have the approval of NHS England. This implementation of OpenSAFELY is hosted within the TPP environment which is accredited to the ISO 27001 information security standard and is NHS IG Toolkit compliant []; Patient data has been pseudonymised for analysis and linkage using industry standard cryptographic hashing techniques; all pseudonymised datasets transmitted for linkage onto OpenSAFELY are encrypted; access to the platform is via a virtual private network (VPN) connection, restricted to a small group of researchers; the researchers hold contracts with NHS England and only access the platform to initiate database queries and statistical models; all database activity is logged; only aggregate statistical outputs leave the platform environment following best practice for anonymisation of results such as statistical disclosure control for low cell counts []. The OpenSAFELY research platform adheres to the obligations of the UK General Data Protection Regulation (GDPR) and the Data Protection Act 2018. In March 2020, the Secretary of State for Health and Social Care used powers under the UK Health Service (Control of Patient Information) Regulations 2002 (COPI) to require organisations to process confidential patient information for the purposes of protecting public health, providing healthcare services to the public and monitoring and managing the COVID-19 outbreak and incidents of exposure; this sets aside the requirement for patient consent []. This was extended in November 2022 for the NHS England OpenSAFELY COVID-19 research platform []. In some cases of data sharing, the common law duty of confidence is met using, for example, patient consent or support from the Health Research Authority Confidentiality Advisory Group []. Taken together, these provide the legal bases to link patient datasets on the OpenSAFELY platform. GP practices, from which the primary care data are obtained, are required to share relevant health information to support the public health response to the pandemic, and have been informed of the OpenSAFELY analytics platform.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Information governance and ethical approval"}},{"value":"BG and OpenSAFELY has received research funding from the Laura and John Arnold Foundation, the NHS National Institute for Health Research (NIHR), the NIHR School of Primary Care Research, NHS England, the NIHR Oxford Biomedical Research Centre, the Mohn-Westlake Foundation, NIHR Applied Research Collaboration Oxford and Thames Valley, the Wellcome Trust, the Good Thinking Foundation, Health Data Research UK, the Health Foundation, the World Health Organisation, UKRI MRC, Asthma UK, the British Lung Foundation, and the Longitudinal Health and Wellbeing strand of the National Core Studies programme; he is a Non-Executive Director at NHS Digital; he also receives personal income from speaking and writing for lay audiences on the misuse of science. AM has received consultancy fees (from https:\/\/ inductionhealthcare.com) and is member of RCGP health informatics group and the NHS Digital GP data Professional Advisory Group that advises on access to GP Data for Pandemic Planning and Research (GDPPR). For the latter, he received payment for the GDPPR role.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"102"}}